Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Rituxan tests positive in Phase III trial
Fierce Pharma
Thursday, September 17, 2009 - 11:11am
tags:
Rituxan, Genentech, lymphoma
Drugmaker Merck, British research charity to develop vaccines for diseases in poor countries
Yahoo/AP
Thursday, September 17, 2009 - 11:08am
tags:
Merck, UK, vaccines
Cloak and Dagger Developments at Cel-Sci Against Swine Flu
Seeking Alpha
Thursday, September 17, 2009 - 9:43am
tags:
Cel-Sci, swine flu, H1N1, vaccines
FDA Panel Backs Auxilium's (AUXL) XIAFLEX
Street Insider
Thursday, September 17, 2009 - 8:33am
tags:
FDA, Auxilium, Xiaflex
Can Anthera whet investors' appetite for biotech IPOs?
Fierce Biotech
Thursday, September 17, 2009 - 8:30am
tags:
IPOs, Anthera
Allergan gets FDA warning on Latisse Web site
Yahoo/AP
Thursday, September 17, 2009 - 8:29am
tags:
FDA, Latisse, Allergan, warnings
Which Pharma Pipelines Rank Best?
Yahoo/Morningstar
Thursday, September 17, 2009 - 8:26am
tags:
pipelines, AstraZeneca, Abbott Laboratories, Bristol-Myers Squibb, GSK, Novartis
ImmunoGen licenses technology to Amgen
Yahoo/AP
Wednesday, September 16, 2009 - 6:13pm
tags:
Immunogen, licensing, Amgen, cancer
FDA orders warning on Phenergan
Philadelphia Inquirer, PA
Wednesday, September 16, 2009 - 6:12pm
tags:
black box, FDA, Phenergan, Wyeth
Novartis Aims Big in COPD Market
Yahoo/Zacks.com
Wednesday, September 16, 2009 - 5:58pm
tags:
Novartis, COPD, GSK, Pfizer
Drug stocks advance; Lundbeck up 4%
Marketwatch
Wednesday, September 16, 2009 - 4:28pm
tags:
drug stocks, Baxter International, Lundbeck
Stats show weakness in Q4 NDAs
Fierce Pharma
Wednesday, September 16, 2009 - 4:26pm
tags:
NDA, FDA
Cell Therapeutics posts follow-up cancer drug data
Yahoo/AP
Wednesday, September 16, 2009 - 4:25pm
tags:
Cell Therapeutics, lymphoma, pixantrone
A Rise For Biopharma In The Fall?
CNBC
Wednesday, September 16, 2009 - 3:53pm
tags:
biotech, Arena Pharmaceuticals, Orexigen, Vivus, Amgen, Celgene
BioCryst Warns Peramivir Sales May Not Bring Profits
TheStreet.com
Wednesday, September 16, 2009 - 10:29am
tags:
Biocryst, peramivir, Amgen, Genzyme, Celgene
Genzyme: Short Term Traders Are Throwing Out the Baby with the Bathwater
Seeking Alpha
Wednesday, September 16, 2009 - 10:01am
tags:
Genzyme
Neurocrine signs financing deal worth up to $75M
Yahoo/AP
Wednesday, September 16, 2009 - 10:00am
tags:
Neurocrine
Savient sticks to Krystexxa resubmission target
Marketwatch
Wednesday, September 16, 2009 - 9:12am
tags:
Savient, Krystexxa, gout
Vivus Can Teach Old Drugs New Tricks, But Does It Have a Bidil Problem?
InVivo
Wednesday, September 16, 2009 - 9:12am
tags:
Vivus, Qnexa, Bidil, obesity
Analyst thinks sales of Arena's lorcaserin will trail other obesity drugs, downgrades stock
Yahoo/AP
Wednesday, September 16, 2009 - 9:10am
tags:
downgrades, Arena Pharmaceuticals, obesity, lorcaserin, Vivus, Orexigen

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.